These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12665493

  • 1. Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability.
    Ayoub IM, Kolarova J, Yi Z, Trevedi A, Deshmukh H, Lubell DL, Franz MR, Maldonado FA, Gazmuri RJ.
    Circulation; 2003 Apr 08; 107(13):1804-9. PubMed ID: 12665493
    [Abstract] [Full Text] [Related]

  • 2. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide.
    Gazmuri RJ, Ayoub IM, Hoffner E, Kolarova JD.
    Circulation; 2001 Jul 10; 104(2):234-9. PubMed ID: 11447092
    [Abstract] [Full Text] [Related]

  • 3. Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury.
    Wang S, Radhakrishnan J, Ayoub IM, Kolarova JD, Taglieri DM, Gazmuri RJ.
    J Appl Physiol (1985); 2007 Jul 10; 103(1):55-65. PubMed ID: 17431086
    [Abstract] [Full Text] [Related]

  • 4. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1.
    Gazmuri RJ, Ayoub IM, Kolarova JD, Karmazyn M.
    Crit Care Med; 2002 Apr 10; 30(4 Suppl):S166-71. PubMed ID: 11940795
    [Abstract] [Full Text] [Related]

  • 5. AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest.
    Radhakrishnan J, Kolarova JD, Ayoub IM, Gazmuri RJ.
    Transl Res; 2011 Feb 10; 157(2):71-80. PubMed ID: 21256459
    [Abstract] [Full Text] [Related]

  • 6. Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation.
    Kolarova J, Yi Z, Ayoub IM, Gazmuri RJ.
    Chest; 2005 Apr 10; 127(4):1327-34. PubMed ID: 15821211
    [Abstract] [Full Text] [Related]

  • 7. Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation.
    Ayoub IM, Kolarova J, Kantola RL, Sanders R, Gazmuri RJ.
    Crit Care Med; 2005 Nov 10; 33(11):2599-605. PubMed ID: 16276186
    [Abstract] [Full Text] [Related]

  • 8. Optimal timing for electrical defibrillation after prolonged untreated ventricular fibrillation.
    Kolarova J, Ayoub IM, Yi Z, Gazmuri RJ.
    Crit Care Med; 2003 Jul 10; 31(7):2022-8. PubMed ID: 12847399
    [Abstract] [Full Text] [Related]

  • 9. Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide.
    Fujii M, Avkiran M, Chambers DJ.
    Ann Thorac Surg; 2004 Apr 10; 77(4):1398-407. PubMed ID: 15063274
    [Abstract] [Full Text] [Related]

  • 10. Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity.
    Ayoub IM, Kolarova J, Gazmuri RJ.
    Resuscitation; 2010 Jan 10; 81(1):106-10. PubMed ID: 19853351
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic defibrillation.
    Wann SR, Weil MH, Sun S, Tang W, Pellis T.
    Crit Care Med; 2002 Apr 10; 30(4 Suppl):S154-6. PubMed ID: 11953643
    [Abstract] [Full Text] [Related]

  • 12. Sodium-hydrogen exchange inhibition attenuates in vivo porcine myocardial stunning.
    Stevens RM, Salik Jahania M, Mentzer RM, Lasley RD.
    Ann Thorac Surg; 2004 Feb 10; 77(2):651-7. PubMed ID: 14759454
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx.
    Gazmuri RJ, Hoffner E, Kalcheim J, Ho H, Patel M, Ayoub IM, Epstein M, Kingston S, Han Y.
    J Lab Clin Med; 2001 Jan 10; 137(1):43-55. PubMed ID: 11150023
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple treatment approach to limit cardiac ischemia-reperfusion injury.
    Davies JE, Digerness SB, Killingsworth CR, Zaragoza C, Katholi CR, Justice RK, Goldberg SP, Holman WL.
    Ann Thorac Surg; 2005 Oct 10; 80(4):1408-16. PubMed ID: 16181879
    [Abstract] [Full Text] [Related]

  • 17. Cariporide for pharmacologic defibrillation after prolonged cardiac arrest.
    Wann SR, Weil MH, Sun S, Tang W, Yu T.
    J Cardiovasc Pharmacol Ther; 2002 Jul 10; 7(3):161-9. PubMed ID: 12232565
    [Abstract] [Full Text] [Related]

  • 18. Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo.
    Aye NN, Komori S, Hashimoto K.
    Br J Pharmacol; 1999 Jun 10; 127(4):1048-55. PubMed ID: 10433514
    [Abstract] [Full Text] [Related]

  • 19. Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes postresuscitation myocardial dysfunction through benefits on energy metabolism.
    Ayoub IM, Kolarova JD, Kantola RL, Radhakrishnan J, Wang S, Gazmuri RJ.
    Crit Care Med; 2007 Oct 10; 35(10):2329-36. PubMed ID: 17944021
    [Abstract] [Full Text] [Related]

  • 20. Cariporide is cardioprotective after iatrogenic ventricular fibrillation in the intact swine heart.
    Rabkin DG, Cabreriza SE, Cheema FH, Hill AA, Curtis LJ, Sciacca RR, Mosca RS, Spotnitz HM.
    Ann Thorac Surg; 2003 Oct 10; 76(4):1264-9; discussion 1269. PubMed ID: 14530023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.